Title |
Protective effect of pioglitazone on morphine-induced neuroinflammation in the rat lumbar spinal cord
|
---|---|
Published in |
Journal of Biomedical Science, September 2015
|
DOI | 10.1186/s12929-015-0187-2 |
Pubmed ID | |
Authors |
Mohammad Charkhpour, Hamed Ghavimi, Saeed Ghanbarzadeh, Bahman Yousefi, Arash Khorrami, Mehran Mesgari, Kambiz Hassanzadeh |
Abstract |
Morphine-induced tolerance is associated with the spinal neuroinflammation. The aim of this study was to explore the effects of oral administration of the pioglitazone, the peroxisome proliferator activated receptor gamma (PPAR-γ) agonist, on the morphine-induced neuroinflammation in the lumbar region of the male Wistar rat spinal cord. Co-administration of the pioglitazone with morphine not only attenuated morphine-induced tolerance, but also prevented the up-regulation of pro-inflammatory cytokines (tumor necrosis factor alpha, interleukin-1beta, and interleukin 6) and nuclear factor-kappa B activity. Administration of the GW-9662 antagonized the above mentioned effects of the pioglitazone. It is concluded that oral administration of the pioglitazone attenuates morphine-induced tolerance and the neuroinflammation in the lumbar region of the rat spinal cord. This action of the pioglitazone may be, at least in part, due to an interaction with the spinal pro-inflammatory cytokine expression and the nuclear factor-kappa B activity. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 5% |
Egypt | 1 | 5% |
Unknown | 20 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Professor > Associate Professor | 4 | 18% |
Student > Ph. D. Student | 4 | 18% |
Researcher | 3 | 14% |
Student > Master | 2 | 9% |
Other | 1 | 5% |
Other | 4 | 18% |
Unknown | 4 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 23% |
Medicine and Dentistry | 3 | 14% |
Neuroscience | 3 | 14% |
Biochemistry, Genetics and Molecular Biology | 1 | 5% |
Chemistry | 1 | 5% |
Other | 0 | 0% |
Unknown | 9 | 41% |